AM, B., G, A., SS, B., ML, B., K, B., CL, C., . . . F, E. (2024). Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: First interim analysis. Therapeutic advances in chronic disease, 15, 20406223241247643. https://doi.org/10.1177/20406223241247643
Chicago Style (17th ed.) CitationAM, Boot, et al. "Real-world Non-interventional Post-authorization Safety Study of Long-term Use of Burosumab in Children and Adolescents with X-linked Hypophosphatemia: First Interim Analysis." Therapeutic Advances in Chronic Disease 15 (2024): 20406223241247643. https://doi.org/10.1177/20406223241247643.
MLA (9th ed.) CitationAM, Boot, et al. "Real-world Non-interventional Post-authorization Safety Study of Long-term Use of Burosumab in Children and Adolescents with X-linked Hypophosphatemia: First Interim Analysis." Therapeutic Advances in Chronic Disease, vol. 15, 2024, p. 20406223241247643, https://doi.org/10.1177/20406223241247643.
